Safety and Efficacy of AR/101 in Accelerating Re-epithelialization of Split Thickness Wounds

Clinical trial NCT02602184 · UNKNOWN

Trial details

NCT number: NCT02602184
Sponsor: Arava Bio Tech Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Wounds and Injuries

Start date: 2015-11-01
Primary completion: 2017-06-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.